Clover Health Files 8-K on Financials
Ticker: CLOV · Form: 8-K · Filed: Mar 12, 2024 · CIK: 1801170
| Field | Detail |
|---|---|
| Company | Clover Health Investments, Corp. /De (CLOV) |
| Form Type | 8-K |
| Filed Date | Mar 12, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, financial-statements, results-of-operations
Related Tickers: CLOV
TL;DR
Clover Health dropped an 8-K detailing its financials - check it for the latest numbers.
AI Summary
Clover Health Investments Corp. filed an 8-K on March 12, 2024, to report on its results of operations and financial condition, and to file financial statements and exhibits. The filing details the company's financial performance and provides updated information for investors.
Why It Matters
This filing provides crucial updates on Clover Health's financial performance, offering insights into its operational results and condition for investors and stakeholders.
Risk Assessment
Risk Level: medium — 8-K filings often contain material information that can impact a company's stock price, requiring careful review.
Key Players & Entities
- CLOVER HEALTH INVESTMENTS, CORP. (company) — Filer
- 0001801170 (company) — Central Index Key
- 20240312 (date) — Filing Date
- 3401 Mallory Lane, Suite 210 Franklin, Tennessee 37067 (address) — Principal Executive Offices
- 001-39252 (company) — SEC File Number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Clover Health Investments Corp.'s Results of Operations and Financial Condition, and to file Financial Statements and Exhibits.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on March 12, 2024.
What is Clover Health Investments Corp.'s principal executive office address?
Clover Health Investments Corp.'s principal executive office is located at 3401 Mallory Lane, Suite 210, Franklin, Tennessee 37067.
What is the Commission File Number for Clover Health Investments Corp.?
The Commission File Number for Clover Health Investments Corp. is 001-39252.
What is the IRS Employer Identification Number for Clover Health Investments Corp.?
The IRS Employer Identification Number for Clover Health Investments Corp. is 98-1515192.
Filing Stats: 544 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-03-12 16:07:20
Key Financial Figures
- $0.0001 — stered Class A Common Stock, par value $0.0001 per share CLOV The NASDAQ Stock Market
Filing Documents
- clov-20240312.htm (8-K) — 27KB
- a12312023-earningsrelease.htm (EX-99.1) — 208KB
- 0001801170-24-000063.txt ( ) — 378KB
- clov-20240312.xsd (EX-101.SCH) — 2KB
- clov-20240312_lab.xml (EX-101.LAB) — 22KB
- clov-20240312_pre.xml (EX-101.PRE) — 13KB
- clov-20240312_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On March 12, 2024, Clover Health Investments, Corp. issued a press release announcing its financial results for the fourth quarter and for its full year ended December 31, 2023. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information set forth in this Item 2.02 (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) List of Exhibits Exhibit No. Description 99.1 Press release dated March 12, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Clover Health Investments, Corp. Date: March 12, 2024 By: /s/ Terrence Ronan Name: Terrence Ronan Title: Interim Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)